«Pancreatitis

Below is an extended Pancreatitis patents listing. Click here to return to the Pancreatitis main in depth entry.

Patents :
US Patent No.	Title
7407959	Cathepsin cysteine protease inhibitors
7410955	Therapeutic use of agonist ligands specific to G2A receptor
7410956	Caspase inhibitor prodrugs
7410962	Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
7410970	Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
7410976	Spirochromanone derivatives
7410984	Compounds
7411037	Polypeptides encoded by a nucleic acid underexpressed in melanoma
7411039	GLP-2 compounds, formulations, and uses thereof
7411040	PRO6182 polypeptides
7411047	PRO6097 antibodies
7410779	Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
7410776	Polypeptides, their production and use
7409297	Methods and systems for providing a nutraceutical program specific to an individual animal
7407961	Pyrazine derivatives and pharmaceutical use thereof
7407964	Caspase inhibitors and uses thereof
7408024	Somatostatin antagonists
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7408034	PRO20025 polypeptides
7408035	PRO9864 polypeptides
7408038	Secreted immunomodulatory proteins
7408042	Anti-PRO6181 antibodies
7408047	Fibroblast growth factor-like polypeptides
7411051	Antibodies to HDPPA04 polypeptide
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7417042	Compounds for enzyme inhibition
7417059	Substituted aromatic-ring compounds, process for producing the same and use
7417060	Aminoalcohol derivatives
7417115	PRO6027 polypeptides
7417116	PRO7155 polypeptides
7417121	Human G-protein coupled receptor, HGPRBMY39
7417123	PRO4399 Antibodies
7417125	Antibodies that bind a PRO1158 polypeptide
7417152	4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B.sub.1 receptor antagonists for the treatment of inflammatory diseases
7417169	Amino alcohol derivatives, medicinal composition containing the same, and use of these
7417029	Prodrug of an ice inhibitor
7416885	Proliferated cell lines and uses thereof
7416857	Differential diagnosis with hepcidin
7411057	Nucleic acids encoding human monoclonal antibodies to CTLA-4
7411071	Modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
7411509	System and method for observing patients in geographically dispersed health care locations
7413871	Scoring method for determining pancreas suitability for islet isolation
7414023	Peptide ligands for prostate specific antigen
7414037	Hydrazide-containing CFTR inhibitor compounds and uses thereof
7414050	Inhibitors of c-fms kinase
7414052	Phenylaminopropanol derivatives and methods of their use
7414131	Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
7416848	DNA encoding SNORF25 receptor
7418292	Device and method for attenuating an immune response

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.